BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11743048)

  • 1. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
    Al-Maghrabi J; Vorobyova L; Chapman W; Jewett M; Zielenska M; Squire JA
    Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal instability detected by interphase fluorescence in situ hybridization and its relation to p53 alteration in prostate carcinoma in Saudi patients.
    Al-Maghrabi JA
    Saudi Med J; 2005 Mar; 26(3):379-84. PubMed ID: 15806203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.
    Vukovic B; Park PC; Al-Maghrabi J; Beheshti B; Sweet J; Evans A; Trachtenberg J; Squire J
    Oncogene; 2003 Apr; 22(13):1978-87. PubMed ID: 12673203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of p53 mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of microdissected specimens.
    Yasunaga Y; Shin M; Fujita MQ; Nonomura N; Miki T; Okuyama A; Aozasa K
    Lab Invest; 1998 Oct; 78(10):1275-9. PubMed ID: 9800953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization.
    Qian J; Bostwick DG; Takahashi S; Borell TJ; Herath JF; Lieber MM; Jenkins RB
    Cancer Res; 1995 Nov; 55(22):5408-14. PubMed ID: 7585610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
    Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
    Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
    Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
    Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 protein and gene alterations in pathological stage C prostate carcinoma.
    Salem CE; Tomasic NA; Elmajian DA; Esrig D; Nichols PW; Taylor CR; Skinner DG; Roy-Burman P; Lieskovsky G; Cote RJ
    J Urol; 1997 Aug; 158(2):510-4. PubMed ID: 9224335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of numerical chromosomal changes detected by interphase fluorescence in situ hybridization in high-grade prostate intraepithelial neoplasia as a predictor of carcinoma.
    Al-Maghrabi J; Vorobyova L; Toi A; Chapman W; Zielenska M; Squire JA
    Arch Pathol Lab Med; 2002 Feb; 126(2):165-9. PubMed ID: 11825111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis.
    Tsujimoto Y; Takayama H; Nonomura N; Okuyama A; Aozasa K
    Prostate; 2002 Sep; 52(4):279-87. PubMed ID: 12210488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
    Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
    Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia.
    Humphrey PA; Swanson PE
    Pathol Res Pract; 1995 Sep; 191(9):881-7. PubMed ID: 8606869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
    Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
    Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
    Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.